🔎 Trials Near Me

Beranda › Kanker Payudara › Minnesota › Plymouth

Uji klinis Kanker Payudara di Plymouth, MN

8 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Plymouth (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Fairview Clinics and Surgery Center Maple Grove, Maple Grove · 4 mi jauhnya
  • Minnesota Oncology - Maple Grove, Maple Grove · 4 mi jauhnya
  • Ridgeview Medical Center, Waconia · 20 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Minnesota Oncology-Sarah Cannon Research Institute, Maple Grove · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07287917

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Menerima pesertaFase 3
  • Fairview Clinics and Surgery Center Maple Grove, Maple Grove · 4 mi jauhnya
  • Minnesota Oncology - Maple Grove, Maple Grove · 4 mi jauhnya
  • Ridgeview Medical Center, Waconia · 20 mi jauhnya
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Menerima pesertaFase 2/3
  • Minnesota Oncology Hematology, Maple Grove · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06926868

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Menerima pesertaFase 3
  • Minnesota Oncology, Maple Grove · 4 mi jauhnya
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05232916

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Menerima pesertaFase 3
  • Minnesota Oncology Hematology, P.A., Plymouth
  • Minnesota Oncology Hematology, P.A., Maple Grove · 4 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Menerima pesertaFase 3
  • Fairview Clinics and Surgery Center Maple Grove, Maple Grove · 4 mi jauhnya
  • Ridgeview Medical Center, Waconia · 20 mi jauhnya
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Ridgeview Medical Center, Waconia · 20 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

Uji klinis Kanker Payudara di kota lain

Studi lain di Plymouth

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.